KR20250038714A - 니코틴아미드모노뉴클레오티드가 봉입되어 있는 장내세균총 개선용 장용성 캡슐제 - Google Patents

니코틴아미드모노뉴클레오티드가 봉입되어 있는 장내세균총 개선용 장용성 캡슐제 Download PDF

Info

Publication number
KR20250038714A
KR20250038714A KR1020257004804A KR20257004804A KR20250038714A KR 20250038714 A KR20250038714 A KR 20250038714A KR 1020257004804 A KR1020257004804 A KR 1020257004804A KR 20257004804 A KR20257004804 A KR 20257004804A KR 20250038714 A KR20250038714 A KR 20250038714A
Authority
KR
South Korea
Prior art keywords
intestinal flora
enteric
improving intestinal
capsule
intestinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020257004804A
Other languages
English (en)
Korean (ko)
Inventor
메구미 타나카
츠네마루 타나카
히로아키 키타노
아야코 야치에
사미크 고쉬
Original Assignee
메구미 타나카
츠네마루 타나카
히로아키 키타노
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메구미 타나카, 츠네마루 타나카, 히로아키 키타노 filed Critical 메구미 타나카
Publication of KR20250038714A publication Critical patent/KR20250038714A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/20—Ingredients acting on or related to the structure
    • A23V2200/224—Encapsulating agent
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020257004804A 2022-07-21 2023-07-21 니코틴아미드모노뉴클레오티드가 봉입되어 있는 장내세균총 개선용 장용성 캡슐제 Pending KR20250038714A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022116167 2022-07-21
JPJP-P-2022-116167 2022-07-21
PCT/JP2023/026741 WO2024019141A1 (ja) 2022-07-21 2023-07-21 ニコチンアミドモノヌクレオチドが封入されている腸内細菌叢改善用腸溶性カプセル剤

Publications (1)

Publication Number Publication Date
KR20250038714A true KR20250038714A (ko) 2025-03-19

Family

ID=89617960

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020257004804A Pending KR20250038714A (ko) 2022-07-21 2023-07-21 니코틴아미드모노뉴클레오티드가 봉입되어 있는 장내세균총 개선용 장용성 캡슐제

Country Status (6)

Country Link
US (1) US20260027144A1 (cg-RX-API-DMAC7.html)
EP (1) EP4559327A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2024019141A1 (cg-RX-API-DMAC7.html)
KR (1) KR20250038714A (cg-RX-API-DMAC7.html)
CN (1) CN119584872A (cg-RX-API-DMAC7.html)
WO (1) WO2024019141A1 (cg-RX-API-DMAC7.html)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190089733A (ko) 2018-01-23 2019-07-31 주식회사 네패스 반도체 칩 적층 패키지 및 그 제조 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
JP2007112805A (ja) * 2002-07-22 2007-05-10 Meito Sangyo Co Ltd ラクトバシラス・カゼイ亜種カゼイ増殖促進用組成物
US20160346303A1 (en) * 2014-10-29 2016-12-01 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
KR20180046692A (ko) * 2016-10-28 2018-05-09 롯데제과 주식회사 과민성 대장증후군 개선용 조성물
JP7128459B2 (ja) 2017-11-15 2022-08-31 株式会社神鋼環境ソリューション 腸内細菌叢改善剤
JP2019170335A (ja) 2018-03-29 2019-10-10 焼津水産化学工業株式会社 腸内短鎖脂肪酸生成促進組成物
WO2020166527A1 (ja) * 2019-02-12 2020-08-20 めぐみ 田中 乳幼児用飲食品、乳幼児の腸内環境の改善方法、及び乳幼児の免疫力の増強方法
JP7488556B2 (ja) * 2020-06-15 2024-05-22 株式会社山田養蜂場本社 細菌の腸内における数を調整するための剤、腸内代謝物質量調整剤、及び便通改善剤
CN111617064A (zh) * 2020-06-24 2020-09-04 渤海大学 大豆种皮多糖在制备调节肠道菌群、降糖降脂以及抗炎症的药物和特医食品中的应用
CN112386581A (zh) * 2020-09-24 2021-02-23 赫曼因生物科技有限公司 一种抗酸肠溶nmn胶囊的包衣配方
CN112089775A (zh) * 2020-10-30 2020-12-18 成都及禾生物科技有限公司 一种nmn有益菌健康组合物及其制备方法和应用
CN112972426A (zh) * 2021-02-23 2021-06-18 成都西域从容生物科技有限公司 一种含nmn的胶囊及其制备方法
CN113633626B (zh) * 2021-07-28 2022-09-27 山东润德生物科技有限公司 一种nmn的胶囊包衣及nmn胶囊制备方法与应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190089733A (ko) 2018-01-23 2019-07-31 주식회사 네패스 반도체 칩 적층 패키지 및 그 제조 방법

Also Published As

Publication number Publication date
WO2024019141A1 (ja) 2024-01-25
US20260027144A1 (en) 2026-01-29
EP4559327A1 (en) 2025-05-28
EP4559327A4 (en) 2026-07-08
CN119584872A (zh) 2025-03-07
JPWO2024019141A1 (cg-RX-API-DMAC7.html) 2024-01-25

Similar Documents

Publication Publication Date Title
US11696921B2 (en) Synthetic composition for microbiota modulation
JP6882931B2 (ja) プレバイオティック製剤および使用方法
KR102741265B1 (ko) 미생물총 조절을 위한 인간 밀크 올리고당 및 그의 합성 조성물
US10471084B2 (en) Composition and method for treating acute respiratory tract infections
US11278558B2 (en) Synthetic composition for microbiota modulation
JP2021152062A (ja) 過敏性腸症候群の治療のための合成組成物および方法
CN108348536B (zh) 治疗抗生素相关性并发症的合成组合物
CN108541221A (zh) Hmo的混合物
US11541067B2 (en) HMO compositions and methods for reducing detrimental proteolytic metabolites
US20200330492A1 (en) Synthetic composition
CN113194961A (zh) 用于促进肠道屏障愈合的组合物和方法
CA2838309C (en) Oligosaccharides composition for preventing or reducing the risk of metabolic syndrome
CN112165947A (zh) 用于治疗自身免疫性疾病的hmo混合物
US20210038545A1 (en) Use of short-chain fatty acids for the treatment of bacterial superinfections post-influenza
US20260027144A1 (en) Enteric capsule for improving intestinal bacterial flora encapsulating nicotinamide mononucleotide
WO2022091075A1 (en) Combination compositions of probiotics with fermented wheat germ extract and uses thereof
US20220400729A1 (en) Synergistic combination of butyric-acid-producing prebiotics and probiotics
JP2025106426A (ja) 腸内短鎖脂肪酸産生促進用組成物及びこれを含む飲食品
HK1240143A (en) Application of thick-wall fungus probiotics in preventing and/or treating diabetes and related diseases thereof
HK1240143A1 (en) Application of thick-wall fungus probiotics in preventing and/or treating diabetes and related diseases thereof
HK1240096A (en) Application of intestinal probiotics in preventing and/or treating diabetes and related diseases thereof
HK1239568A (en) Application of thick-wall fungus probiotics in treatment and prevention of obesity and related diseases
HK1240096A1 (en) Application of intestinal probiotics in preventing and/or treating diabetes and related diseases thereof
HK1239568A1 (en) Application of thick-wall fungus probiotics in treatment and prevention of obesity and related diseases

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20250213

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application